← Leaderboards

Randall J Bateman

Washington University

Google Scholar ↗PubMed ↗ORCID ↗

$192,965,895

Attributed

$192,965,895

Total exposure

28

Grants

27

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $36.5M · FY2005–25

$50M$37.5M$25M$12.5M$0

'05

'06

'07

'08

'09

'10

'11

'12

'13

'14

'15

'16

'17

'18

'19

'20

'21

'22

'23

'24

'25

Funding mix

By agency

NIH$255,876,606 · 30

By mechanism

R01$145,193,273 · 6

U19$62,507,286 · 3

UF1$24,430,150 · 2

U01$10,375,718 · 2

RF1$6,875,527 · 1

R56$4,602,923 · 2

Top collaborators

No co-investigators on record.

Most similar at Washington University

Same institution · by research overlap

Fong-Fu Hsu$2,424,678
Michael L Gross$20,301,359
Sheng-Kwei Song$14,973,079
John Morris$91,785,862
Daniel S Ory$14,176,962

Others in their field

Top investigators on “Alzheimer&Apos”

Jose A Luchsinger · Columbia University Health Sciences$56,595,040
Eric M Reiman · Banner Health$48,982,487
Yadong Huang · J. David Gladstone Institutes$40,311,515
Lindsay A. Farrer · Boston University Medical Campus$34,189,802
David M Holtzman · Washington University$28,985,806
Michael W Weiner · Northern California Institute Res &Educ$28,197,224

Research focus

Alzheimer&AposS DiseaseParticipantBiological MarkersDesignImageAmyloid Beta-ProteinInheritedFunctional DisorderSymptomsDementiaPositron-Emission TomographyEnrollmentCognitiveAmyloidCerebrospinal FluidFundingProtocols DocumentationTau ProteinsImpaired CognitionProductionBiologicalInternationalPharmaceutical Preparations

Grant awards (89)

DIAN-TU: Tau Next Generation Prevention Trial$16,269,865

R01 · FY2025 · AG · contact PI

Bridge Funding for Dominantly Inherited Alzheimer Network$7,994,551

U19 · FY2025 · AG · contact PI

Blood amyloid, tau, and neurodegeneration biomarkers and prediction of clinical onset, cognitive decline, and dementia diagnosis$5,409,374

R01 · FY2025 · AG · contact PI

DIAN-TU: Tau Next Generation Prevention Trial$105,120

R01 · FY2025 · AG · contact PI

Blood amyloid, tau, and neurodegeneration biomarkers and prediction of clinical onset, cognitive decline, and dementia diagnosis$5,175,354

R01 · FY2024 · AG · contact PI

Dominantly Inherited Alzheimer Network$5,643,579

U19 · FY2023 · AG · contact PI

DIAN-TU: Next Generation Prevention Trial$5,486,752

R01 · FY2023 · AG · contact PI

Dominantly Inherited Alzheimer Network Administrative Core$3,716,640

U19 · FY2023 · AG · contact PI

Dominantly Inherited Alzheimer Network$804,156

U19 · FY2023 · AG · contact PI

DIAN-TU: Tau Next Generation Prevention Trial$16,720,909

R01 · FY2022 · AG · contact PI

Dominantly Inherited Alzheimer Network$6,556,948

U19 · FY2022 · AG · contact PI

DIAN-TU: Next Generation Prevention Trial$6,473,282

R01 · FY2022 · AG · contact PI

Dominantly Inherited Alzheimer Network Administrative Core$5,616,806

U19 · FY2022 · AG · contact PI

DIAN-TU: Tau Next Generation Prevention Trial$14,975,441

R01 · FY2021 · AG · contact PI

Dominantly Inherited Alzheimer Network$6,724,923

U19 · FY2021 · AG · contact PI

Dominantly Inherited Alzheimer Network Administrative Core$3,435,298

U19 · FY2021 · AG · contact PI

DIAN-TU: Tau Next Generation Prevention Trial - Administrative Supplement$1,768,000

R01 · FY2021 · AG · contact PI

DIAN-TU: Tau Next Generation Prevention Trial$14,973,241

R01 · FY2020 · AG · contact PI

DIAN-TU: Next Generation Prevention Trial$9,215,083

R01 · FY2020 · AG · contact PI

Dominantly Inherited Alzheimer Network$5,747,863

U19 · FY2020 · AG · contact PI

Dominantly Inherited Alzheimer Network Administrative Core$2,394,859

U19 · FY2020 · AG · contact PI

Blood amyloid-beta relationship with amyloid plaques and CSF amyloid-beta$1,180,828

RF1 · FY2020 · AG · contact PI

Dominantly Inherited Alzheimer Network$1,170,427

U19 · FY2020 · AG · contact PI

CNS TAU KINETICS IN ALZHEIMER'S DISEASE$709,046

R01 · FY2020 · NS · contact PI

Characterization of Neurofilament Light Chain in Alzheimer's Disease and Other Neurodegenerative Disorders$432,938

R21 · FY2020 · AG · contact PI

Dominantly Inherited Alzheimer Network$356,883

U19 · FY2020 · AG · contact PI

Dominantly Inherited Alzheimer Network$321,405

U19 · FY2020 · AG · contact PI

Dominantly Inherited Alzheimer Network$6,058,792

U19 · FY2019 · AG · contact PI

Blood amyloid-beta relationship with amyloid plaques and CSF amyloid-beta$5,694,699

RF1 · FY2019 · AG · contact PI

Dominantly Inherited Alzheimer's Network Trials Unit - Adaptive Prevention Trial$5,316,057

R01 · FY2019 · AG · contact PI

DIAN-TU Next Generation Prevention Trial$4,035,654

R01 · FY2019 · AG · contact PI

Dominantly Inherited Alzheimer Network Administrative Core$2,535,326

U19 · FY2019 · AG · contact PI

DIAN-TU Next Generation Prevention Trial - Data Request Management Supplement$760,916

R01 · FY2019 · AG · contact PI

CNS TAU KINETICS IN ALZHEIMER'S DISEASE$710,952

R01 · FY2019 · NS · contact PI

Dominantly Inherited Alzheimer's Network Trials Unit - Adaptive Prevention Trial$5,232,087

R01 · FY2018 · AG · contact PI

DIAN-TU: Next Generation Prevention Trial$4,488,042

R01 · FY2018 · AG · contact PI

DOMINANTLY INHERITED ALZHEIMER NETWORK TRIAL: AN OPPORTUNITY TO PREVENT DEMENTIA$1,501,190

U01 · FY2018 · AG · contact PI

Blood amyloid-beta relationship with amyloid plaques and CSF amyloid-beta$1,371,044

R56 · FY2018 · AG · contact PI

CNS TAU KINETICS IN ALZHEIMER'S DISEASE$731,915

R01 · FY2018 · NS · contact PI

Dominantly Inherited Alzheimer's Network Trials Unit - Adaptive Prevention Trial$5,258,914

R01 · FY2017 · AG · contact PI

DIAN-TU: Next Generation Prevention Trial$4,488,040

R01 · FY2017 · AG · contact PI

Dominantly Inherited Alzheimer Network$3,495,735

UF1 · FY2017 · AG · contact PI

CNS TAU KINETICS IN ALZHEIMER'S DISEASE$733,821

R01 · FY2017 · NS · contact PI

Dominantly Inherited Alzheimer's Network Trials Unit - Adaptive Prevention Trial$5,232,530

R01 · FY2016 · AG · contact PI

DIAN-TU: Next Generation Prevention Trial$3,231,879

R56 · FY2016 · AG · contact PI

DOMINANTLY INHERITED ALZHEIMER NETWORK TRIAL: AN OPPORTUNITY TO PREVENT DEMENTIA$1,500,000

U01 · FY2016 · AG · contact PI

DOMINANTLY INHERITED ALZHEIMER NETWORK TRIAL: AN OPPORTUNITY TO PREVENT DEMENTIA$917,915

U01 · FY2016 · AG · contact PI

CNS TAU KINETICS IN ALZHEIMER'S DISEASE$748,660

R01 · FY2016 · NS · contact PI

CNS and Plasma Amyloid--Beta Kinetics in Alzheimer's Disease$535,836

R01 · FY2016 · NS · contact PI

Dominantly Inherited Alzheimer Network$99,908

UF1 · FY2016 · AG · contact PI

The Dominantly Inherited Alzheimer Disease Family Conference$74,999

R13 · FY2016 · AG · contact PI

DOMINANTLY INHERITED ALZHEIMER NETWORK TRIAL: AN OPPORTUNITY TO PREVENT DEMENTIA$1,455,000

U01 · FY2015 · AG · contact PI

CNS and Plasma Amyloid--Beta Kinetics in Alzheimer's Disease$583,083

R01 · FY2015 · NS · contact PI

Dominantly Inherited Alzheimer Network$17,935,541

UF1 · FY2014 · AG · contact PI

Dominantly Inherited Alzheimer's Network Trials Unit - Adaptive Prevention Trial$5,525,079

R01 · FY2014 · AG · contact PI

DIAN Clinical Core$2,898,966

UF1 · FY2014 · AG · contact PI

DOMINANTLY INHERITED ALZHEIMER NETWORK TRIAL: AN OPPORTUNITY TO PREVENT DEMENTIA$1,500,000

U01 · FY2014 · AG · contact PI

Clinical$1,091,780

U19 · FY2014 · AG · contact PI

CNS and Plasma Amyloid--Beta Kinetics in Alzheimer's Disease$577,250

R01 · FY2014 · NS · contact PI

DOMINANTLY INHERITED ALZHEIMER NETWORK TRIAL: AN OPPORTUNITY TO PREVENT DEMENTIA$500,000

U01 · FY2014 · AG · contact PI

DOMINANTLY INHERITED ALZHEIMER NETWORK TRIAL: AN OPPORTUNITY TO PREVENT DEMENTIA$1,500,000

U01 · FY2013 · AG · contact PI

Clinical$766,257

U19 · FY2013 · AG · contact PI

CNS and Plasma Amyloid--Beta Kinetics in Alzheimer's Disease$572,336

R01 · FY2013 · NS · contact PI

Clinical$798,865

U19 · FY2012 · AG · contact PI

CNS and Plasma Amyloid--Beta Kinetics in Alzheimer's Disease$598,260

R01 · FY2012 · NS · contact PI

A BETA METABOLISM IN ALZHEIMER DISEASE & CONTROLS$499,103

R01 · FY2011 · NS · contact PI

DECREASED CLEARANCE OF CNS AMYLOID-? IN ALZHEIMER?S DISEASE$13,051

P41 · FY2011 · RR · contact PI

ACUTE GAMMA-SECRETASE INHIBITION OF NONHUMAN PRIMATE CNS SHIFTS AMYLOID$4,273

P41 · FY2011 · RR · contact PI

A GAMMA-SECRETASE INHIBITOR DECREASES AMYLOID-BETA PRODUCTION IN THE CENTRAL$4,042

P41 · FY2011 · RR · contact PI

Clinical$771,928

U19 · FY2010 · AG · contact PI

A BETA METABOLISM IN ALZHEIMER DISEASE & CONTROLS$423,006

R01 · FY2010 · NS · contact PI

alphabeta AND PROTEOMIC ANALYSIS OF CSF IN AD AND AGING$188,680

K23 · FY2010 · AG · contact PI

APOE METABOLISM IN AD AND CONTROLS$187,181

P50 · FY2010 · AG · contact PI

A GAMMA-SECRETASE INHIBITOR DECREASES AMYLOID-BETA PRODUCTION IN THE CENTRAL$11,261

P41 · FY2010 · RR · contact PI

Clinical$744,798

U01 · FY2009 · AG · contact PI

A BETA METABOLISM IN ALZHEIMER DISEASE & CONTROLS$411,393

R01 · FY2009 · NS · contact PI

alphabeta AND PROTEOMIC ANALYSIS OF CSF IN AD AND AGING$184,749

K23 · FY2009 · AG · contact PI

STABLE ISOTOPE LABELING TANDEM MASS SPETROMETRY (SILT) TO QUANTIFY PROTEIN$9,306

P41 · FY2009 · RR · contact PI

Clinical$756,815

U01 · FY2008 · AG · contact PI

A BETA METABOLISM IN ALZHEIMER DISEASE & CONTROLS$448,872

R01 · FY2008 · NS · contact PI

alphabeta AND PROTEOMIC ANALYSIS OF CSF IN AD AND AGING$180,933

K23 · FY2008 · AG · contact PI

HUMAN AMYLOID - SYNTHESIS AND CLEARANCE RATES AS MEASURED IN CEREBROSPINAL FLUID$8,349

P41 · FY2008 · RR · contact PI

alphabeta AND PROTEOMIC ANALYSIS OF CSF IN AD AND AGING$200,037

K23 · FY2007 · AG · contact PI

IN VIVO METABOLISM OF AMYLOID-BETA IN HUMAN CSF$10,166

M01 · FY2007 · RR · contact PI

amyloid-beta metabolism/humans/Alzheimer's Disease$169,992

K08 · FY2006 · AG · contact PI

IN VIVO METABOLISM OF AMYLOID-BETA IN HUMAN CSF$31,652

M01 · FY2006 · RR · contact PI

amyloid-beta metabolism/humans/Alzheimer's Disease$170,262

K08 · FY2005 · AG

IN VIVO METABOLISM OF AMYLOID-BETA IN HUMAN CSF$8,626

M01 · FY2005 · RR

IN VIVO-LABELING OF AMYLOID-BETA IN HUMAN CSF$1,232

M01 · FY2005 · RR